
    
      To evaluate if a monthly adherence monitoring and education service impacts the percent of
      patients adherent to oral diabetes and renin-angiotensin system antagonists (RASA)
      medications based on star ratings. It will also evaluate patient satisfaction of the
      adherence monitoring and education service, using a standard questionnaire.
    
  